Bromodomain and Extra-Terminal Protein (BET) Inhibitor

Overview

BET Inhibitors work by blocking chemicals that tell cancer cells to grow.

Explore Tags

Myeloma Treatments

The following is a listing of myeloma treatments associated with this tag.

All Treatments

View all treatments in development for myeloma patients around the US.

Verified RO6870810
RO6870810

RO6870810 is a BET inhibitor that is openly enrolling in a dose expansion clinical trial around the US.

SparkCures Verified Accurate, up-to-date information. Learn more


Early Relapse Multiple Myeloma

The following is a listing of treatments in development for patients with multiple myeloma who have received one to two prior lines of therapy.

Late Relapse Multiple Myeloma

The following is a listing of treatments in development for patients with multiple myeloma who have received three or more prior lines of therapy.

Verified RO6870810
RO6870810

RO6870810 is a BET inhibitor that is openly enrolling in a dose expansion clinical trial around the US.

SparkCures Verified Accurate, up-to-date information. Learn more


Resources

There are no resources, links or videos to display for this tag.